This is frequently diagnosed in dogs that were never spayed and the only type of cancer in dogs that has research showing ...

A 56-year-old man achieves remission from aggressive stage 4 non-Hodgkin's lymphoma after undergoing innovative CAR-T cell therapy at Medanta Hospital, overcoming prior treatment failures and serious ...

DelveInsight's “Hairy Cell Leukemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given ...

The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...

Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given ...

Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses. Read why I maintain a Hold ...

Herpes simplex virus (HSV), the viral agent causing human genital herpes, recurs easily and poses significant harm to patients, while also being associated with atherosc ...